Genetic Testing in South Africa

By Crystal Lubbe

February 13, 2025

Could genetic testing be the key to preventing sudden cardiac deaths in South Africa? The recent study investigated the use of genetic testing in South Africa, specifically through next-generation sequencing (NGS), to identify genetic causes of sudden unexpected deaths (SUD) in a young South African cohort. It analysed DNA from 51 SUD cases, focusing on 49 genes linked to inherited cardiac arrhythmogenic disorders. The findings revealed that approximately 4% of the deaths were likely due to genetic arrhythmic or cardiac conduction disorders. This study highlights the importance of genetic testing in understanding and preventing sudden cardiac deaths in South Africa.

Key Insights into Genetic Testing

The study identified 175 different missense variants, with 92.5% being known and documented, and 7.4% being novel. Most variants were of benign or likely benign significance, while a small percentage were pathogenic or of unknown significance. Post-mortem genetic testing revealed that about 4% (2/51) of the SUD cases had a genetic arrhythmic or cardiac conduction disorder as the probable cause of death. The study emphasises the need for better detection, treatment, and prevention of sudden cardiac deaths in South Africa, especially in light of the significant increase in noncommunicable diseases, particularly cardiovascular diseases. Utilising NGS and the Galaxy bioinformatic platform for variant annotation and interpretation demonstrates the potential of advanced genetic testing to elucidate the causes of sudden unexpected deaths.

Public Health Concerns Globally

Sudden cardiac death is a major public health concern globally. In sub-Saharan Africa, including South Africa, it accounts for an estimated 50% of all cardiovascular deaths. Unfortunately, there is a lack of reliable statistics on its incidence in these regions.
Previous studies have shown the value of genetic testing in determining the underlying causes of sudden unexpected deaths, especially in cases where traditional post-mortem investigations are inconclusive. Research indicates that sudden deaths are more common among males, particularly in the 40-49 age group, and often result from cardiovascular and respiratory incidents. Genetic factors are identified in a small percentage of these cases.

The Transformative Role of Genetic Testing in South Africa: Implications for Health and Society

The integration of next-generation sequencing (NGS) into the investigation of sudden unexpected deaths in South Africa could have profound economic implications. By reducing the need for repeated and costly diagnostic procedures, early identification of genetic causes can lead to targeted preventive measures and treatment strategies, potentially lowering healthcare costs over time. From a public health perspective, the insights gained from genetic testing can significantly inform strategies aimed at preventing sudden cardiac deaths. By identifying genetic predispositions, public health programs can focus on genetic screening and counseling, ultimately leading to improved health outcomes and reduced mortality rates.

For families affected by sudden unexpected deaths, genetic testing offers the possibility of closure by providing a clearer understanding of the cause of death. It also has important genetic implications for family members, enabling early intervention and preventive measures that can safeguard their health. Moreover, the study emphasises the necessity for more comprehensive epidemiological data on sudden cardiac deaths in South Africa. Such data is crucial for policymakers to develop and implement effective health strategies and interventions, addressing the growing burden of cardiovascular diseases.

In conclusion, genetic testing in South Africa is an essential tool for uncovering the underlying genetic causes of sudden unexpected deaths. It not only enhances healthcare outcomes but also helps in devising strategies to mitigate associated risks, thereby playing a transformative role in the health and well-being of individuals and communities.

Reference url

Recent Posts

Ending Unproven Fertility Treatments: NICE Calls for Evidence-Based Care in Clinics

By João L. Carapinha

September 10, 2025

Unproven fertility treatments—a term referring to add-on procedures without robust clinical evidence—have come under renewed scrutiny in the UK. Many prospective parents want to know: Why are unproven fertility treatments being discouraged, and what does this mean for fertility clinic choices...
Medicare ACO Outcomes: Balancing Surgical Benefits and Costs Under the TEAM Model

By João L. Carapinha

September 9, 2025

Medicare ACO outcomes are a major focus for clinicians, policymakers, and researchers seeking to understand how Accountable Care Organization (ACO) assignment influences patient results and healthcare costs after surgery. Are ACOs improving quality and saving money for Medicare patients undergoin...
UK Risks Underestimating Life Sciences Investment Potential

By Staff Writer

September 8, 2025

Life sciences investment UK is at a crucial crossroads. As the government relies on the Green Book framework to guide funding for manufacturing innovation, many experts question whether the true value of advanced life sciences manufacturing is being fully recognized. How does the current appraisa...